Used blister packets that contained medicines, tablets and pills are seen in this picture illustration taken June 30, 2018. In this Exchange podcast, Dr. Steffen Denzinger, president of the European Fine Chemicals Group, argues that safeguarding medicines may require patients to pay more. Listen to the podcastFollow @aimeedonnellan on XSubscribe to Breakingviews’ podcasts, Viewsroom and The Exchange. Editing by Oliver TaslicOur Standards: The Thomson Reuters Trust Principles. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.

---

Persons: Russell Boyce, Steffen Denzinger, Oliver Taslic Organizations: REUTERS, Reuters, European Fine Chemicals Group, Thomson